Skip to main content

Find Clinical Trials

Home
Conditions
Urogenital Neoplasms

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

123 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Completed

Assessing the Patient Experience in Cancer Care

NCT01621295

Conditions: Brain Diseases, Brain Neoplasm, Brain Neoplasms, +44 more
Locations: Los Angeles County Hospital Los Angeles, California, United States

University of Southern California - Norris Los Angeles, California, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin

NCT01599013

Conditions: Bladder Transitional Cell Carcinoma Stage IV, Carcinoma, Carcinoma, Transitional Cell, +19 more
Locations: Pierre Fabre Research Institute Boulogne, France

View Trial Details

Completed

Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass

NCT01433302

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +24 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study Using WST11 in Patients With Localized Prostate Cancer

NCT00975429

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Centre Hospitalier Universitaire (CHU) Angers, France

Hôpital Claude Huriez Lille, France

Institut Mutualiste Montsouris(IMM) Paris, France

Catharina Ziekenhuis Eindhoven, Netherlands

View Trial Details

Completed

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

NCT00753415

Conditions: Adenocarcinoma, Bladder Carcinoma, Breast Cancer, +56 more
Locations: Not specified

View Trial Details

Completed

A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)

NCT00749502

Conditions: Adnexal Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +38 more
Locations: Not specified

View Trial Details

Completed

Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma

NCT01441661

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Tongji Hospital, Tongji Medical College of Hust Wuhan, Hubei, China

View Trial Details

Completed

Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients

NCT01523652

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: ASO Ordine Mauriziano Turin, Italy

View Trial Details

Completed

SUTENT® In The First Line Treatment Of Renal Cell Carcinoma

NCT00460798

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Not specified

View Trial Details

Completed

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

NCT00377520

Conditions: Cancer of Endometrium, Cancer of the Endometrium, Endometrial Cancer, +15 more
Locations: Gynecologic Oncology Group 215-854-0770 Philadelphia, Pennsylvania, United States

View Trial Details